C
CIN Terminal
Cannabis Investor News
A CanIDeal Company
All Insights
J

DEA Window Narrows — What U.S. MSOs and Ancillaries Should Price In

DEA post-hearing schedule compresses timing for rescheduling read-throughs; Tilray filings offer a template for fiscal resilience and the risks MSOs/ancillaries must model in a policy-driven regime.

Key takeaways
    Share X LinkedIn Email
    Found this useful? Share it X LinkedIn

    More like this, straight to your inbox

    One new CIN Insight + the week's top three signals from the live terminal. Free, weekly.